Literature DB >> 26464220

Relationship between cutaneous polyarteritis nodosa (cPAN) and macular lymphocytic arteritis (MLA): Blinded histologic assessment of 35 cPAN cases.

Amandine Buffiere-Morgado1, Maxime Battistella1, Marie-Dominique Vignon-Pennamen1, Adèle de Masson1, Michel Rybojad1, Antoine Petit1, Florence Cordoliani1, Edouard Begon1, Béatrice Flageul1, Alfred Mahr1, Martine Bagot1, Jean-David Bouaziz2.   

Abstract

BACKGROUND: Cutaneous polyarteritis nodosa (cPAN) is a skin medium vessel neutrophilic arteritis with livedo, nodules, and ulcerations. Macular lymphocytic arteritis (MLA) is a small arteritis with erythematous or pigmented macules and typical histologic features (a lymphocytic infiltrate, concentric fibrin ring, no disruption of the internal elastic lamina).
OBJECTIVE: We sought to assess the frequency of clinical and histologic features of MLA in patients with cPAN.
METHODS: This was a monocentric retrospective analysis of patients given the diagnosis of cPAN with blinded assessment of skin biopsy specimens.
RESULTS: All 35 patients included had an infiltrated livedo, nodules, or both. Ulceration was rare. Erythematous or pigmented lesions were present in 54% of patients. Predominantly lymphocytic arteritis, a paucity of neutrophils, concentric fibrin ring, and absence of internal lamina elastic disruption were present in 60%, 20%, 18%, and 23% of patients, respectively. Median follow-up was 11 years. None of the patients had systemic involvement, and 57% had a complete remission. The incidence of complete remission was not different between patients having a predominant lymphocyte infiltrate or few neutrophils. LIMITATIONS: This was a retrospective, monocentric study without a control group of patients with MLA.
CONCLUSIONS: Our data do not favor the classification of cPAN and MLA as distinct entities.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cutaneous periarteritis nodosa; lymphocytic thrombophilic arteritis; macular arteritis; macular lymphocytic arteritis; periarteritis nodosa; vasculitis

Mesh:

Year:  2015        PMID: 26464220     DOI: 10.1016/j.jaad.2015.09.010

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.

Authors:  Francois Chasset; Camille Francès
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 10.817

Review 2.  Update on vasculitis: overview and relevant dermatological aspects for the clinical and histopathological diagnosis - Part II.

Authors:  Thâmara Cristiane Alves Batista Morita; Paulo Ricardo Criado; Roberta Fachini Jardim Criado; Gabriela Franco S Trés; Mirian Nacagami Sotto
Journal:  An Bras Dermatol       Date:  2020-05-24       Impact factor: 1.896

3.  Macular arteritis in an HIV-infected patient improving with adherence to antiretroviral therapy.

Authors:  Elisabeth Boddé; Jeffrey Damman; Martijn B A van Doorn
Journal:  JAAD Case Rep       Date:  2020-06-14

4.  Serologic Abnormalities in Macular Lymphocytic Arteritis with Case Presentation.

Authors:  Nicole R Bender; Elizabeth L Bisbee; Douglas Robins; Kiran Motaparthi; Vladimir Vincek
Journal:  Case Rep Dermatol       Date:  2022-01-17

Review 5.  Cutaneous Vasculitis: Review on Diagnosis and Clinicopathologic Correlations.

Authors:  Laure Frumholtz; Sara Laurent-Roussel; Dan Lipsker; Benjamin Terrier
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.